167081-31-4

Basic information

• Product Name: Carbamic acid, [(1R,3S)-3-(hydroxymethyl)cyclopentyl]-, 1,1-dimethylethyl ester, rel-
• CAS NO: 167081-31-4
• Molecular Formula: C11H21NO3
• Mol File: 167081-31-4.mol
• Article Data: 22

Chemical Properties

• CAS DataBase Reference: Carbamic acid, [(1R,3S)-3-(hydroxymethyl)cyclopentyl]-, 1,1-dimethylethyl ester, rel-(CAS DataBase Reference)
• NIST Chemistry Reference: Carbamic acid, [(1R,3S)-3-(hydroxymethyl)cyclopentyl]-, 1,1-dimethylethyl ester, rel-(167081-31-4)
• EPA Substance Registry System: Carbamic acid, [(1R,3S)-3-(hydroxymethyl)cyclopentyl]-, 1,1-dimethylethyl ester, rel-(167081-31-4)

Safety Data

• Hazardous Substances Data: 167081-31-4(Hazardous Substances Data)

Upstream product

• 24424-99-5 di-tert-butyl dicarbonate 
• 329910-39-6 (1S,3S)-1-(tert-butoxycarbonylamino)cyclopentane-3-carboxylic acid methyl ester 
• 167081-32-5 3-oxo-2-aza-bicyclo[2.2.1]hept-5-ene-2-carboxylic acid tert-butyl ester 
• 49805-30-3 2-azabicyclo[2.2.1.]hept-5-en-3-one 
• 162427-15-8 3-oxo-2-aza-bicyclo[2.2.1]hept-5-ene-2-carboxylic acid tert-butyl ester 
• 1400583-12-1 trans-(+/-)-methyl 3-N-boc-aminocyclopentane-1-carboxylate 
• 161660-94-2 (1R,3S)-3-((tert-butoxycarbonyl)amino)cyclopentane-1-carboxylic acid 
• 108999-93-5 (1SR,4RS)-4-[(tert-butyloxycarbonyl)amino]cyclopent-2-enecarboxylic acid 
• 49805-30-3 racemic 2-azabicyclo[2.2.1]hept-5-en-3-one 
• 130931-83-8 (1S,4R)-2-azabicyclo[2,2,1]hept-5-en-3-one 
• 71830-07-4 (1S,3R)-3-aminocyclopentanecarboxylic acid 
• 200002-41-1 (-)-[(1R,4S)-tert-butyl 3-oxo-2-azabicyclo(2.2.1)hept-5-ene-2-carboxylate] 
• 134003-02-4 (-)-2-Azabicyclo<2.2.1>heptan-3-one 
• 153011-43-9 (1S,cis)-tert-butyl N-[4-(hydroxymethyl)-2-cyclopenten-1-yl]carbamate 

Downstream Products

• 1110772-11-6 ((1S,3R)-3-aminocyclopentyl)methanol 
• 862700-28-5 cis-(+/-)-3-N-Boc-aminocyclopentylmethylamine 
• 862700-28-5 tert-butyl (3-(aminomethyl)cyclopentyl)carbamate 
• 117957-62-7 (1S,3R)-1-amino-3-(hydroxymethyl)cyclopentanone 
• 551964-49-9 ((1R,3S)-3-formyl-cyclopentyl)-carbamic acid tert-butyl ester 

Relevant articles and documents

Synthesis and evaluation of cyclopentane-based muraymycin analogs targeting MraY

Antibiotic resistance is one of the most challenging global health issues and presents an urgent need for the development of new antibiotics. In this regard, phospho-MurNAc-pentapeptide translocase (MraY), an essential enzyme in the early stages of peptid

PYRAZOLYL COMPOUNDS AND METHODS OF USE THEREOF

Compounds having activity as chemotherapeutic agents are provided. The compounds have the following structure (I): or a pharmaceutically acceptable salt, stereoisomer, isotopic form or prodrug thereof, wherein R1a, R1b, R1c, R1d, L, and are as defined herein. Methods associated with preparation and use of such compounds, pharmaceutical compositions comprising such compounds and methods for treating cancer (e.g., hematological cancers) are also provided.

MACROCYCLIC INHIBITORS OF MYELOPEROXIDASE

The present invention provides compounds of Formula (I): wherein the substituents are as defined in the specification, and compositions comprising any of such novel compounds. These compounds are myeloperoxidase (MPO) inhibitors and/or eosinophil peroxidase (EPX) inhibitors, and may be useful for for the treatment and/or prophylaxis of atherosclerosis, heart failure, chronic obstructive pulmonary disease (COPD), and related diseases.